NEW YORK (GenomeWeb) – Roche said late on Tuesday that Pathology Inc. has become a Roche Molecular Center of Excellence for the next five years.

With the designation, Pathology's molecular diagnostic laboratory will be able to offer molecular technologies from Roche, such as the US Food and Drug Administration-approved cobas HPV test, to physicians and patients. The test helps clinicians assess a patient's risk of cervical cancer based on the presence of clinically relevant high-risk HPV DNA.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.